PDS5B-DT: A Potential Drug Target for Cancer (G107984584)

Target Name: PDS5B-DT

NCBI ID: G107984584

PDS5B-DT

Other Name(s): Linc1749808 | PDS5B divergent transcript

PDS5B-DT: A Potential Drug Target for Cancer

Proteostasis is the control system that regulates the balance of protein synthesis and degradation in cells. Disruptions in this system can lead to a wide range of diseases, including cancer, neurodegenerative diseases, and developmental disorders. The protein-protein interactions (PPIs) play a crucial role in maintaining protein homeostasis and have been implicated in many diseases. One of the most promising targets for new therapies is the protein involved in the maintenance of cellular homeostasis, PDS5B-DT (Linc1749808), which has been shown to be involved in a variety of cellular processes, including cell adhesion, migration, and survival.

PDS5B-DT: A Potential Drug Target

PDS5B-DT, also known as Linc1749808, is a protein that is expressed in many different tissues and cells, including neurons, endothelial cells, and epithelial cells. It is a member of the PDS5B family, which is known for its role in regulating protein-protein interactions and is composed of at least 11 different proteins. PDS5B-DT is a 21 kDa protein that is expressed in high levels in many tissues, including brain, heart, and pancreas.

PDS5B-DT has been shown to be involved in a variety of cellular processes that are important for maintaining cellular homeostasis. One of the most well-studied functions of PDS5B-DT is its role in cell adhesion. PDS5B-DT is a critical protein for the formation of tight junctions, which are the major barrier between epithelial cells and are involved in the regulation of ion and solute transport. In addition to its role in cell adhesion, PDS5B-DT has also been shown to be involved in cell migration, a critical process for the development and maintenance of tissues and organs.

In addition to its role in cell adhesion and migration, PDS5B-DT has also been shown to be involved in a variety of other cellular processes that are important for maintaining cellular homeostasis. For example, PDS5B-DT has been shown to play a role in the regulation of cell survival and has been shown to protect against a variety of cellular stressors, including reactive oxygen species (ROS), which are highly reactive molecules that can damage cellular components and contribute to a wide range of diseases, including cancer.

The Role of PDS5B-DT in Cancer

The regulation of cell adhesion and survival is a critical factor in the development and progression of cancer. PDS5B-DT has been shown to play a role in both of these processes and has been implicated in the development and progression of a variety of cancers. For example, studies have shown that PDS5B-DT is expressed in many different types of cancer, including breast, lung, and ovarian cancer. In addition, PDS5B-DT has been shown to be involved in the regulation of cell survival and has been shown to protect against the effects of chemotherapy and radiation therapy in a variety of cancer types.

The potential therapeutic use of PDS5B-DT as a drug target is due to its involvement in the regulation of cellular homeostasis and its role in the development and progression of cancer. By targeting PDS5B-DT with small molecules or other therapeutic agents, it may be possible to disrupt its function and disrupt the growth and survival of cancer cells. This is an exciting area of research and has the potential to lead to new and effective therapies for a variety of diseases.

Conclusion

PDS5B-DT is a protein that is involved in a variety of cellular processes that are important for maintaining cellular homeostasis. Its role in cell adhesion, migration, and survival, as well as its involvement in the regulation of

Protein Name: PDS5B Divergent Transcript

The "PDS5B-DT Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PDS5B-DT comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets